Results 241 to 250 of about 7,765,653 (401)

Complementary and alternative medicine use among US cancer survivors

Journal of cancer survivorship, 2016
G. John, D. Hershman, Laura Falci, Zaixing Shi, W. Tsai, H. Greenlee   +5 more
semanticscholar   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Parental management of autoimmune disease with complementary and alternative medicine: a scoping review of the literature in OECD countries. [PDF]

BMC Complement Med Ther
Maio J, Smith CA, Ward PR.
europepmc   +1 more source

Physicians Providing Alternative Medicine Boundary Crossing and the Emergence of Integrative Medicine

, 2000
R.J. Lockwood
openalex   +2 more sources

Complementary and alternative medicine in chronic liver disease [PDF]

, 2001
Leonard B. Seeff, Karen L. Lindsay, Bruce R. Bacon, Thomas F. Kresina, Jay H. Hoofnagle   +4 more
openalex   +1 more source

Medical alternatives to alternative medicine [PDF]

Cancer, 1999
openaire   +2 more sources

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

Molecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa, Julia Richert, Tomasz Stokowy, Alicja Staśczak, Mariusz Szajewski, Maciej Ciesielski, Petra M. Grešner, Bartłomiej Tomasik, Łukasz Arcimowicz, Agnieszka Stankiewicz, Grażyna Suchodolska, Elżbieta Senkus, Wiesław Kruszewski, Anna J. Żaczek, Aleksandra Markiewicz   +14 more
wiley   +1 more source

Complementary and alternative medicine use among patients with type-2 diabetes mellitus attending a suburban tertiary healthcare centre in Sri Lanka. [PDF]

BMC Complement Med Ther
Thilakarathna M, Appuhami K, Darshana N, Perera J.   +3 more
europepmc   +1 more source

The Prevalence and Predictors of the Use of Alternative Medicine in Presurgical Patients in Five California Hospitals

, 2001
Jacqueline M. Leung, Samir Dzankic, Kawalpreet Manku, San Yuan   +3 more
openalex   +1 more source

Research into complementary and alternative medicine: problems and potential [PDF]

, 2001
Richard L. Nahin
openalex   +1 more source